Lexology January 29, 2024
- Funding Challenges for Medical Devices and Technology – The uncertain economy has slowed investment and lowered valuations, but family offices, venture capital (VC), private equity (PE), and strategic investors continue to invest in disruptive and best-in-class products.
- M&A Remains Most Common Exit – With the IPO window staying closed for medtech and fundraising difficult, M&A will be the main exit in 2024. Potential targets should de-risk their commercial, regulatory, and IP strategies and be prepared for deeper due diligence.
- Intellectual Property (IP) Drives Investment and M&A – Building a strategic IP portfolio of patents, trademarks, and trade...
Today's Sponsors
Today's Sponsor